<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <title>Cancer Prevention Lab</title>
  <link>https://cancerpreventionlab.com</link>
  <description>Evidence-based cancer prevention research. We analyze clinical trials, meta-analyses, and emerging evidence on cancer prevention and repurposed treatments.</description>
  <language>en-us</language>
  <lastBuildDate>Mon, 30 Mar 2026 03:00:00 GMT</lastBuildDate>
  <atom:link href="https://cancerpreventionlab.com/feed.xml" rel="self" type="application/rss+xml"/>
  <item><title>Fenbendazole for Cancer: The Joe Tippens Protocol Examined</title><link>https://cancerpreventionlab.com/treatments/fenbendazole/</link><description>A veterinary dewormer with real preclinical data but zero human trials. We break down the Joe Tippens story, the liver toxicity reports, and why mebendazole is the smarter choice.</description><pubDate>Mon, 30 Mar 2026 02:00:00 GMT</pubDate></item>
  <item><title>Best Cancer Prevention Supplements 2026</title><link>https://cancerpreventionlab.com/prevention/best-supplements-2026/</link><description>Every supplement ranked by human clinical evidence. Tier 1 (take these), Tier 2 (promising), and what to avoid.</description><pubDate>Mon, 30 Mar 2026 02:00:00 GMT</pubDate></item>
  <item><title>Fenbendazole vs Mebendazole: The Evidence Comparison</title><link>https://cancerpreventionlab.com/compare/fenbendazole-vs-mebendazole/</link><description>Same mechanism, vastly different evidence. Side-by-side comparison with clear winner.</description><pubDate>Mon, 30 Mar 2026 02:00:00 GMT</pubDate></item>
  <item><title>Ivermectin for Cancer: Multi-Target Mechanism and the First Human Trial</title><link>https://cancerpreventionlab.com/treatments/ivermectin/</link><description>Nobel Prize-winning drug with impressive preclinical data. The Cedars-Sinai Phase I/II trial is underway. But can anticancer doses be safely achieved?</description><pubDate>Mon, 30 Mar 2026 02:00:00 GMT</pubDate></item>
  <item><title>The Joe Tippens Protocol: Every Component Graded by Evidence</title><link>https://cancerpreventionlab.com/treatments/joe-tippens-protocol/</link><description>Fenbendazole + curcumin + CBD + vitamin E. One component may increase cancer risk. Evidence-based alternatives provided.</description><pubDate>Mon, 30 Mar 2026 02:00:00 GMT</pubDate></item>
  <item><title>GcMAF: The Retracted Fraud That Still Exploits Cancer Patients</title><link>https://cancerpreventionlab.com/debunked/gcmaf/</link><description>Three papers retracted. Main seller jailed for 15 months. Products still sold online.</description><pubDate>Mon, 30 Mar 2026 02:00:00 GMT</pubDate></item>
  <item><title>High-Dose IV Vitamin C: The Trial That Doubled Pancreatic Cancer Survival</title><link>https://cancerpreventionlab.com/treatments/high-dose-vitamin-c/</link><description>A Phase II RCT at the University of Iowa doubled overall survival in metastatic pancreatic cancer.</description><pubDate>Mon, 30 Mar 2026 01:00:00 GMT</pubDate></item>
  <item><title>Mebendazole: The $5 FDA-Approved Drug With Cancer Trial Data</title><link>https://cancerpreventionlab.com/treatments/mebendazole/</link><description>FDA-approved dewormer with Phase I/II data in glioblastoma and colorectal cancer. Crosses the blood-brain barrier.</description><pubDate>Mon, 30 Mar 2026 01:00:00 GMT</pubDate></item>
  <item><title>The Galleri Multi-Cancer Blood Test: Is $950/Year Worth It?</title><link>https://cancerpreventionlab.com/prevention/galleri-test/</link><description>PATHFINDER 2 showed 7x increased cancer detection. We analyze what that means.</description><pubDate>Mon, 30 Mar 2026 01:00:00 GMT</pubDate></item>
  <item><title>High-Dose Melatonin: The 34% Cancer Mortality Reduction</title><link>https://cancerpreventionlab.com/prevention/melatonin/</link><description>Meta-analysis of 8 RCTs shows melatonin at 10-20mg reduced cancer mortality by 34%. No toxicity ever established.</description><pubDate>Mon, 30 Mar 2026 01:00:00 GMT</pubDate></item>
  <item><title>Why Metformin Failed for Cancer</title><link>https://cancerpreventionlab.com/debunked/metformin-cancer/</link><description>The MA.32 trial (3,649 patients) killed the metformin-cancer hypothesis. HR 1.01.</description><pubDate>Mon, 30 Mar 2026 01:00:00 GMT</pubDate></item>
</channel>
</rss>
